Feifei Wu
Impact in
- Cancer Research top 5%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
- Neurology top 10%
- Neuroinflammation and Neurodegeneration Mechanisms
Papers in
-
- RNA modifications and cancer 4
- Inflammasome and immune disorders 3
- Plant Gene Expression Analysis 3
-
- Cancer-related molecular mechanisms research 6
- MicroRNA in disease regulation 4
- Co-authors
- Shuying Li (4 shared papers)Huaqiang Li (4 shared papers)Yongping Xu (4 shared papers)Liji Jin (4 shared papers)Jiansong You (2 shared papers)Longxuan Li (2 shared papers)Hai‐Feng Ji (2 shared papers)Rongguo Hu (2 shared papers)
- Journals
- Frontiers in Pharmacology (3 papers)International Journal of Oncology (2 papers)Frontiers in Genetics (2 papers)Journal of Ethnopharmacology (2 papers)European Journal of Medicinal Chemistry (2 papers)
- Partner nations
- ChinaUnited StatesGermany
In The Last Decade
Feifei Wu
54 papers receiving 1.3k citations
Feifei Wu's Hit Papers
Peers
Comparison fields: 5 of 117
- Cancer Research 284
- Neurology 102
- Molecular Biology 711
- Immunology 193
- Pharmaceutical Science 50
Countries citing papers authored by Feifei Wu
This map shows the geographic impact of Feifei Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Feifei Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Feifei Wu more than expected).
Fields of papers citing papers by Feifei Wu
This network shows the impact of papers produced by Feifei Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Feifei Wu. The network helps show where Feifei Wu may publish in the future.
Co-authors
The 25 scholars most cited alongside Feifei Wu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 62 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Exosomes from MiR-30d-5p-ADSCs Reverse Acute Ischemic Stroke-Induced, Autophagy-Mediated Brain Injury by Promoting M2 Microglial/Macrophage Polarization Hit paper breakdown → | 2018 | 263 |
| 2 | 2012 | 157 | |
| 3 | 2023 | 54 | |
| 4 | 2017 | 47 | |
| 5 | 2021 | 47 | |
| 6 | 2013 | 46 | |
| 7 | 2015 | 45 | |
| 8 | 2016 | 41 | |
| 9 | 2015 | 40 | |
| 10 | 2024 | 40 | |
| 11 | 2016 | 38 | |
| 12 | 2020 | 38 | |
| 13 | 2016 | 35 | |
| 14 | 2021 | 31 | |
| 15 | 2015 | 30 | |
| 16 | 2022 | 29 | |
| 17 | 2014 | 28 | |
| 18 | 2020 | 26 | |
| 19 | 2018 | 25 | |
| 20 | 2018 | 21 |
About Feifei Wu
Feifei Wu is a scholar working on Molecular Biology, Cancer Research, Immunology, Cellular and Molecular Neuroscience and Oncology, having authored 62 papers that have together received 1.4k indexed citations. Recurring topics across this work include Cancer-related molecular mechanisms research (6 papers), CAR-T cell therapy research (4 papers), MicroRNA in disease regulation (4 papers), RNA modifications and cancer (4 papers), Advanced Sensor and Energy Harvesting Materials (3 papers), Pain Mechanisms and Treatments (3 papers), Inflammasome and immune disorders (3 papers) and Plant Gene Expression Analysis (3 papers). The work is most often cited by research in Cancer Research (284 citations), Neurology (102 citations), Molecular Biology (711 citations), Immunology (193 citations) and Pharmaceutical Science (50 citations). Feifei Wu has collaborated with scholars based in China, United States and Germany. Frequent co-authors include Shuying Li, Huaqiang Li, Yongping Xu, Liji Jin, Jiansong You, Longxuan Li, Hai‐Feng Ji, Rongguo Hu, Liying Cai and Yufeng Jiang. Their work appears in journals such as Frontiers in Pharmacology, International Journal of Oncology, Frontiers in Genetics, Journal of Ethnopharmacology and European Journal of Medicinal Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.